1 - 25 of
132
results
for author:"Morgan J."
in Literature Citations
| Systematic development of hybrid cybernetic models: application to recombinant yeast co-consuming glucose and xylose. Song H.S., Morgan J.A., Ramkrishna D. Biotechnol. Bioeng. 103:984-1002(2009) · Mapped (2) |
| Characterization of trans-neuronal trafficking of Cbln1. Wei P., Rong Y., Li L., Bao D., Morgan J.I. Mol. Cell. Neurosci. 41:258-273(2009) · Mapped (4) |
| Altering sphingolipid metabolism in Saccharomyces cerevisiae cells lacking the amphiphysin ortholog Rvs161 reinitiates sugar transporter endocytosis. Morgan J., McCourt P., Rankin L., Swain E., Rice L.M., Nickels J.T. Jr. Eukaryotic Cell 8:779-789(2009) · Mapped (17) |
| Stress-induced ceramide-activated protein phosphatase can compensate for loss of amphiphysin-like activity in Saccharomyces cerevisiae and functions to reinitiate endocytosis. McCourt P.C., Morgan J.M., Nickels J.T. Jr. J. Biol. Chem. 284:11930-11941(2009) · Mapped (10) |
| Cbln1 accumulates and colocalizes with Cbln3 and GluRdelta2 at parallel fiber-Purkinje cell synapses in the mouse cerebellum. Miura E., Matsuda K., Morgan J.I., Yuzaki M., Watanabe M. Eur. J. Neurosci. 29:693-706(2009) · Mapped (4) |
| Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation. Collins C.A., Gnocchi V.F., White R.B., Boldrin L., Perez-Ruiz A., Relaix F., Morgan J.E., Zammit P.S. PLoS ONE 4:e4475-e4475(2009) · Mapped (8) |
| Two duplicated P450 genes are associated with pyrethroid resistance in Anopheles funestus, a major malaria vector. Wondji C.S., Irving H., Morgan J., Lobo N.F., Collins F.H., Hunt R.H., Coetzee M., Hemingway J., Ranson H. Genome Res. 19:452-459(2009) · UniProtKB (13) |
| Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Cosenza-Nashat M., Zhao M.L., Suh H.S., Morgan J., Natividad R., Morgello S., Lee S.C. Neuropathol. Appl. Neurobiol. 35:306-328(2009) · Mapped (7) |
| Sensorimotor enhancement in mouse mutants lacking the Purkinje cell-specific Gi/o modulator, Pcp2(L7). Iscru E., Serinagaoglu Y., Schilling K., Tian J., Bowers-Kidder S.L., Zhang R., Morgan J.I., DeVries A.C., Nelson R.J., Zhu M.X. et al. Mol. Cell. Neurosci. 40:62-75(2009) · Mapped (3) |
| Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Gurel B., Iwata T., Koh C.M., Jenkins R.B., Lan F., Van Dang C., Hicks J.L., Morgan J., Cornish T.C., Sutcliffe S. et al. Mod. Pathol. 21:1156-1167(2008) · Mapped (8) |
| Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. Barbone D., Yang T.M., Morgan J.R., Gaudino G., Broaddus V.C. J. Biol. Chem. 283:13021-13030(2008) · Mapped (5) |
| SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Vitart V., Rudan I., Hayward C., Gray N.K., Floyd J., Palmer C.N., Knott S.A., Kolcic I., Polasek O., Graessler J. et al. Nat. Genet. 40:437-442(2008) · UniProtKB (1) |
| Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes. Yan X., Schuldt A.J., Price R.L., Amende I., Liu F.F., Okoshi K., Ho K.K., Pope A.J., Borg T.K., Lorell B.H. et al. Am. J. Physiol. Heart Circ. Physiol. 294:H1274-81(2008) · Mapped (3) |
| Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons. Wei P., Smeyne R.J., Bao D., Parris J., Morgan J.I. Eur. J. Neurosci. 26:2962-2978(2007) · Mapped (57) |
| Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Datta S.R., McQuillin A., Puri V., Choudhury K., Thirumalai S., Lawrence J., Pimm J., Bass N., Lamb G., Moorey H. et al. Behav Brain Funct 3:50-50(2007) · Mapped (2) |
| Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Arechavala-Gomeza V., Graham I.R., Popplewell L.J., Adams A.M., Aartsma-Rus A., Kinali M., Morgan J.E., van Deutekom J.C., Wilton S.D., Dickson G. et al. Hum. Gene Ther. 18:798-810(2007) · Mapped (71) |
| Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution. Takenaka K., Morgan J.A., Scheffer G.L., Adachi M., Stewart C.F., Sun D., Leggas M., Ejendal K.F., Hrycyna C.A., Schuetz J.D. Cancer Res. 67:6965-6972(2007) · Mapped (5) |
| Complement C3 variant and the risk of age-related macular degeneration. Yates J.R.W., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F. et al. N. Engl. J. Med. 357:553-561(2007) · UniProtKB (1) · Mapped (5) |
| Carlow virus, a 2002 GII.4 variant Norovirus strain from Ireland. Kearney K., Menton J., Morgan J.G. Virol. J. 4:61-61(2007) · UniProtKB (3) |
| The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Liu W., Baer M.R., Bowman M.J., Pera P., Zheng X., Morgan J., Pandey R.A., Oseroff A.R. Clin. Cancer Res. 13:2463-2470(2007) · Mapped (3) |
| Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease. Pattarini R., Smeyne R.J., Morgan J.I. Neuroscience 145:654-668(2007) · Mapped (5) |
| Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Ichinose F., Buys E.S., Neilan T.G., Furutani E.M., Morgan J.G., Jassal D.S., Graveline A.R., Searles R.J., Lim C.C., Kaneki M. et al. Circ. Res. 100:130-139(2007) · Mapped (3) |
| Cbln1 is essential for interaction-dependent secretion of cbln3. Bao D., Pang Z., Morgan M.A., Parris J., Rong Y., Li L., Morgan J.I. Mol. Cell. Biol. 26:9327-9337(2006) · UniProtKB (4) · Mapped (4) |
| IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis. Schopf L., Savinainen A., Anderson K., Kujawa J., DuPont M., Silva M., Siebert E., Chandra S., Morgan J., Gangurde P. et al. Arthritis Rheum. 54:3163-3173(2006) · Mapped (1) |
| The carboxypeptidase-like substrate-binding site in Nna1 is essential for the rescue of the Purkinje cell degeneration (pcd) phenotype. Wang T., Parris J., Li L., Morgan J.I. Mol. Cell. Neurosci. 33:200-213(2006) · Mapped (12) |
